539267 SAMSRITA

Samsrita Labs Share Price

 

 

Start SIP in SAMSRITA

Start SIP

Performance

  • Low
  • ₹20
  • High
  • ₹22
  • 52 Week Low
  • ₹12
  • 52 Week High
  • ₹26
  • Open Price₹20
  • Previous Close₹21
  • Volume1,819

Investment Returns

  • Over 1 Month -2.18%
  • Over 3 Month + 16.47%
  • Over 6 Month -2.27%
  • Over 1 Year -5.58%

Smart Investing Starts Here Start SIP with Samsrita Labs for Steady Growth!

Invest Now

Samsrita Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -9.2
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 49
  • P/B Ratio
  • Average True Range
  • 1.58
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.11
  • RSI
  • 45.97
  • MFI
  • 17.57

Samsrita Labs Financials

Samsrita Labs Technicals

EMA & SMA

Current Price
₹21.50
+ 1 (4.88%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹21.33
  • 50 Day
  • ₹21.10
  • 100 Day
  • ₹20.85
  • 200 Day
  • ₹20.60

Resistance and Support

20.57 Pivot Speed
  • R3 20.83
  • R2 20.77
  • R1 20.63
  • S1 20.43
  • S2 20.37
  • S3 20.23

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Samsrita Labs has an operating revenue of Rs. 0.30 Cr. on a trailing 12-month basis. Pre-tax margin of 0% needs improvement, ROE of -2% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. It is currently FORMING a base in its weekly chart and is trading around 18% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at D- which indicates heavy supply, Group Rank of 93 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Samsrita Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-10-25 Quarterly Results
2025-09-08 Others Inter-alia, to consider 1. Appointment of Mrs. M. Gita usha Rani as Company Secretary and Compliance Officer of the Company. 2. Other business matters.
2025-07-18 Quarterly Results
2025-04-30 Preferential issue of shares
2025-04-26 Audited Results

Samsrita Labs F&O

Samsrita Labs Shareholding Pattern

31.41%
0%
0%
0%
0%
64.54%
4.05%

Samsrita Labs FAQs

Samsrita Labs share price is ₹21 As on 11 December, 2025 | 13:32

The Market Cap of Samsrita Labs is ₹48.9 Cr As on 11 December, 2025 | 13:32

The P/E ratio of Samsrita Labs is -9.2 As on 11 December, 2025 | 13:32

The PB ratio of Samsrita Labs is 2.4 As on 11 December, 2025 | 13:32

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23